
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8891563
[patent_doc_number] => 20130164747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'Predicting Treatment Response in Cancer Subjects'
[patent_app_type] => utility
[patent_app_number] => 13/654059
[patent_app_country] => US
[patent_app_date] => 2012-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11693
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13654059
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/654059 | Predicting Treatment Response in Cancer Subjects | Oct 16, 2012 | Abandoned |
Array
(
[id] => 8828636
[patent_doc_number] => 20130129681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'METHODS FOR DIAGNOSING SOLID TUMORS'
[patent_app_type] => utility
[patent_app_number] => 13/645325
[patent_app_country] => US
[patent_app_date] => 2012-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 44625
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13645325
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/645325 | METHODS FOR DIAGNOSING SOLID TUMORS | Oct 3, 2012 | Abandoned |
Array
(
[id] => 8755193
[patent_doc_number] => 20130089498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-11
[patent_title] => 'COMPOSITIONS AND METHODS RELATED TO PROFILING A PLURALITY OF CELLS BASED ON PEPTIDE BINDING'
[patent_app_type] => utility
[patent_app_number] => 13/629067
[patent_app_country] => US
[patent_app_date] => 2012-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 26996
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13629067
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/629067 | COMPOSITIONS AND METHODS RELATED TO PROFILING A PLURALITY OF CELLS BASED ON PEPTIDE BINDING | Sep 26, 2012 | Abandoned |
Array
(
[id] => 8732750
[patent_doc_number] => 20130078319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'DETECTION OF OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/624922
[patent_app_country] => US
[patent_app_date] => 2012-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13742
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13624922
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/624922 | DETECTION OF OVARIAN CANCER | Sep 21, 2012 | Abandoned |
Array
(
[id] => 9671631
[patent_doc_number] => 20140235495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'CELL RESPONSE ASSAY FOR CANCER AND METHODS OF PRODUCING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/346638
[patent_app_country] => US
[patent_app_date] => 2012-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11438
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346638
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346638 | CELL RESPONSE ASSAY FOR CANCER AND METHODS OF PRODUCING AND USING SAME | Sep 20, 2012 | Abandoned |
Array
(
[id] => 9413631
[patent_doc_number] => 08697668
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG215 and/or UBP43'
[patent_app_type] => utility
[patent_app_number] => 13/621377
[patent_app_country] => US
[patent_app_date] => 2012-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7969
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13621377
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/621377 | Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG215 and/or UBP43 | Sep 16, 2012 | Issued |
Array
(
[id] => 8794644
[patent_doc_number] => 20130111613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'COLON DISEASE TARGETS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/621466
[patent_app_country] => US
[patent_app_date] => 2012-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42549
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13621466
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/621466 | COLON DISEASE TARGETS AND USES THEREOF | Sep 16, 2012 | Abandoned |
Array
(
[id] => 8606592
[patent_doc_number] => 20130011904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'CYTOTOXIC RIBONUCLEASE VARIANTS'
[patent_app_type] => utility
[patent_app_number] => 13/619192
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13938
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13619192
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/619192 | Cytotoxic ribonuclease variants | Sep 13, 2012 | Issued |
Array
(
[id] => 8756074
[patent_doc_number] => 20130090376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-11
[patent_title] => 'ANTIBODIES TO TUMOR ASSOCIATED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/620170
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 126378
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13620170
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/620170 | Antibodies to tumor associated proteins | Sep 13, 2012 | Issued |
Array
(
[id] => 8606554
[patent_doc_number] => 20130011867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'BLADDER CANCER BIOMARKER AND TEST METHOD USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/614709
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5336
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13614709
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/614709 | BLADDER CANCER BIOMARKER AND TEST METHOD USING THE SAME | Sep 12, 2012 | Abandoned |
Array
(
[id] => 8607237
[patent_doc_number] => 20130012550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'METHODS FOR PROGNOSIS AND MONITORING CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/613909
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17873
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13613909
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/613909 | METHODS FOR PROGNOSIS AND MONITORING CANCER THERAPY | Sep 12, 2012 | Abandoned |
Array
(
[id] => 8707566
[patent_doc_number] => 20130064855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'REPROGRAMMING IMMUNE ENVIRONMENT IN BREAST CANCER VIA DENDRITIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/611976
[patent_app_country] => US
[patent_app_date] => 2012-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12342
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13611976
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/611976 | REPROGRAMMING IMMUNE ENVIRONMENT IN BREAST CANCER VIA DENDRITIC CELLS | Sep 11, 2012 | Abandoned |
Array
(
[id] => 10844278
[patent_doc_number] => 08871451
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Extracellular and membrane-associated prostate cancer markers'
[patent_app_type] => utility
[patent_app_number] => 13/607296
[patent_app_country] => US
[patent_app_date] => 2012-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9506
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13607296
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/607296 | Extracellular and membrane-associated prostate cancer markers | Sep 6, 2012 | Issued |
Array
(
[id] => 8989864
[patent_doc_number] => 20130217145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'ANTIBODIES WHICH DETECT PIVKAII AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/604967
[patent_app_country] => US
[patent_app_date] => 2012-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23214
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13604967
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/604967 | ANTIBODIES WHICH DETECT PIVKAII AND METHODS OF USE THEREOF | Sep 5, 2012 | Abandoned |
Array
(
[id] => 10863661
[patent_doc_number] => 08889354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'Methods for the identification, assessment, and treatment of patients with cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 13/600260
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55946
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 325
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13600260
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/600260 | Methods for the identification, assessment, and treatment of patients with cancer therapy | Aug 30, 2012 | Issued |
Array
(
[id] => 8916759
[patent_doc_number] => 20130178383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'VESICLE ISOLATION METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/598408
[patent_app_country] => US
[patent_app_date] => 2012-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 195
[patent_figures_cnt] => 195
[patent_no_of_words] => 144017
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13598408
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/598408 | VESICLE ISOLATION METHODS | Aug 28, 2012 | Abandoned |
Array
(
[id] => 8916917
[patent_doc_number] => 20130178543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'BIOMARKER FOR DIAGNOSING CANCER AND METHOD OF ISOLATING CANCER CELL USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/594610
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4570
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13594610
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/594610 | BIOMARKER FOR DIAGNOSING CANCER AND METHOD OF ISOLATING CANCER CELL USING THE SAME | Aug 23, 2012 | Abandoned |
Array
(
[id] => 8515865
[patent_doc_number] => 20120315273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'TREATING SKIN CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/591847
[patent_app_country] => US
[patent_app_date] => 2012-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4077
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13591847
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/591847 | TREATING SKIN CANCER | Aug 21, 2012 | Abandoned |
Array
(
[id] => 8708010
[patent_doc_number] => 20130065299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'ACTRIIB-FC POLYNUCLEOTIDES, POLYPEPTIDES, AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/588468
[patent_app_country] => US
[patent_app_date] => 2012-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 23243
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13588468
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/588468 | ACTRIIB-FC polynucleotides, polypeptides, and compositions | Aug 16, 2012 | Issued |
Array
(
[id] => 8566492
[patent_doc_number] => 20120329063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'NOVEL MEANS FOR THE DIAGNOSIS AND THERAPY OF CTCL'
[patent_app_type] => utility
[patent_app_number] => 13/585882
[patent_app_country] => US
[patent_app_date] => 2012-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21004
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13585882
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/585882 | Means for the diagnosis and therapy of CTCL | Aug 14, 2012 | Issued |